TY - JOUR
T1 - A Multidisciplinary Thyroid Eye Clinic
T2 - A One-stop Shop
AU - Zloto, Ofira
AU - Sagiv, Oded
AU - Priel, Ayelet
AU - Cukierman-Yaff, Tali
AU - Tirosh, Amir
AU - Agmon-Levi, Nancy
AU - Madgar, Shiran
AU - Serlin, Tal
AU - Winter, Halit
AU - Huna-Baro, Ruth
AU - Wygnanski-Jaff, Tamara
AU - Simon, Guy Ben
N1 - Publisher Copyright:
© 2022 Israel Medical Association. All rights reserved.
PY - 2022/10
Y1 - 2022/10
N2 - Background: Little is known about the success of multidisciplinary thyroid eye disease (TED) clinic. Objectives: To present the characteristics, treatments, and outcomes of patients treated in a multidisciplinary TED clinic Methods: A medical record review of all patients who attended a TED clinic was performed. Data included demographics, medical history, laboratory tests, visual function tests, ocular examinations, clinical activity score (CAS), and assessment of quality of life (QOL). Results: Clinic visits included 132 patients seen during 385 appointments at a TED clinic (mean 12 appointments per patient). Management of TED included medical treatments for 48 patients (36.3%) and surgical treatment for 56 (42.4%). There was a positive significant correlation between the CAS and thyroid-stimulating immunoglobulin (TSI) activity at the first visit and at the last follow-up visit (P < 0.01 and P < 0.02, respectively). However, no correlation was found between the CAS and the thyroid-stimulating hormone levels or between the free triiodothyronine (fT3) and fT4 levels at the first or last visit. There was a significant negative correlation between the CAS and color vision (-0.347, P < 0.01, Pearson correlation) at the first visit, but not between the CAS and visual acuity and visual field at either the first or last visit. Changes in the QOL and the CAS scores were significantly negatively correlated (-0.240, P < 0.01). Conclusions: Treatment and management decisions for TED should be based on multiple parameters including clinical examinations by ophthalmologists and endocrinologists, laboratory tests, and CAS and QOL scores.
AB - Background: Little is known about the success of multidisciplinary thyroid eye disease (TED) clinic. Objectives: To present the characteristics, treatments, and outcomes of patients treated in a multidisciplinary TED clinic Methods: A medical record review of all patients who attended a TED clinic was performed. Data included demographics, medical history, laboratory tests, visual function tests, ocular examinations, clinical activity score (CAS), and assessment of quality of life (QOL). Results: Clinic visits included 132 patients seen during 385 appointments at a TED clinic (mean 12 appointments per patient). Management of TED included medical treatments for 48 patients (36.3%) and surgical treatment for 56 (42.4%). There was a positive significant correlation between the CAS and thyroid-stimulating immunoglobulin (TSI) activity at the first visit and at the last follow-up visit (P < 0.01 and P < 0.02, respectively). However, no correlation was found between the CAS and the thyroid-stimulating hormone levels or between the free triiodothyronine (fT3) and fT4 levels at the first or last visit. There was a significant negative correlation between the CAS and color vision (-0.347, P < 0.01, Pearson correlation) at the first visit, but not between the CAS and visual acuity and visual field at either the first or last visit. Changes in the QOL and the CAS scores were significantly negatively correlated (-0.240, P < 0.01). Conclusions: Treatment and management decisions for TED should be based on multiple parameters including clinical examinations by ophthalmologists and endocrinologists, laboratory tests, and CAS and QOL scores.
KW - European Group on Graves' Orbi-topathy (EUGOGO)
KW - Graves' disease
KW - clinical activity score (CAS)
KW - quality of life (QOL)
KW - thyroid eye disease (TED)
UR - http://www.scopus.com/inward/record.url?scp=85141004922&partnerID=8YFLogxK
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 36309864
AN - SCOPUS:85141004922
SN - 1565-1088
VL - 24
SP - 671
EP - 676
JO - Israel Medical Association Journal
JF - Israel Medical Association Journal
IS - 10
ER -